Chemcrux Enterprises Ltd

Chemcrux Enterprises Ltd

₹ 185 0.38%
22 Nov - close price
About

Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]

Key Points

Business Overview:[1]
CEL is an ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certified company. It specializes in High Pressure Oxidation, Nitration, Chlorosulfonation and Amidation Chemistry - manufacturing intermediates
for bulk drugs(API), dyes & pigment, electro-plating, pharmaceuticals, dyes and pigments industries

  • Market Cap 274 Cr.
  • Current Price 185
  • High / Low 326 / 182
  • Stock P/E 37.7
  • Book Value 49.8
  • Dividend Yield 0.54 %
  • ROCE 13.5 %
  • ROE 12.0 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 19.4%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
20.01 22.29 15.84 21.81 18.54 17.11 17.76
14.90 18.43 13.50 17.43 15.92 15.05 15.40
Operating Profit 5.11 3.86 2.34 4.38 2.62 2.06 2.36
OPM % 25.54% 17.32% 14.77% 20.08% 14.13% 12.04% 13.29%
0.18 0.18 0.24 0.56 0.35 0.39 0.26
Interest 0.47 0.31 0.21 0.17 0.13 0.13 0.33
Depreciation 0.58 0.57 0.58 0.58 0.55 0.56 0.73
Profit before tax 4.24 3.16 1.79 4.19 2.29 1.76 1.56
Tax % 31.13% 26.27% 30.17% 36.75% 3.49% 29.55% 26.28%
2.92 2.33 1.24 2.66 2.21 1.24 1.15
EPS in Rs 1.97 1.57 0.84 1.80 1.49 0.84 0.78
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 TTM
95.27 95.15 78.47 75.22
74.56 73.69 65.10 63.80
Operating Profit 20.71 21.46 13.37 11.42
OPM % 21.74% 22.55% 17.04% 15.18%
1.00 1.05 1.18 1.56
Interest 0.17 0.82 0.83 0.76
Depreciation 1.59 2.04 2.29 2.42
Profit before tax 19.95 19.65 11.43 9.80
Tax % 25.51% 26.92% 26.16%
14.86 14.36 8.44 7.26
EPS in Rs 10.03 9.70 5.70 4.91
Dividend Payout % 19.93% 20.63% 17.55%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -18%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -41%
Stock Price CAGR
10 Years: %
5 Years: 42%
3 Years: 14%
1 Year: -34%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 14.81 14.81 14.81 14.81
Reserves 39.87 51.60 57.45 58.95
9.75 14.43 26.46 28.71
19.34 12.38 11.15 13.98
Total Liabilities 83.77 93.22 109.87 116.45
25.49 33.11 33.09 56.58
CWIP 0.00 0.31 21.06 1.97
Investments 7.08 16.79 19.83 20.58
51.20 43.01 35.89 37.32
Total Assets 83.77 93.22 109.87 116.45

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
9.16 14.82 16.54
-2.64 -20.48 -25.85
3.96 0.96 7.40
Net Cash Flow 10.49 -4.70 -1.91

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 72.33 51.56 71.17
Inventory Days 92.33 124.92 99.63
Days Payable 92.57 71.19 83.28
Cash Conversion Cycle 72.09 105.28 87.52
Working Capital Days 68.46 79.83 76.94
ROCE % 27.63% 13.46%

Shareholding Pattern

Numbers in percentages

Sep 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
72.94% 72.94% 72.94% 72.94% 72.94% 72.94% 72.94% 72.92% 72.92% 72.92% 72.92% 72.92%
27.06% 27.06% 27.06% 27.06% 27.06% 27.06% 27.07% 27.07% 27.06% 27.09% 27.08% 27.07%
No. of Shareholders 7209978,31123,26227,88930,26630,67032,55932,15930,94628,97727,365

Documents